Replimune competitors and similar companiesClear all

Replimune's competitors and similar companies include 3sbio, Acerta Pharma and Clovis Oncology.

	Replimune Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.	3sbio 3sbio (三生制药集团) is a company that develops biopharmaceuticals.	Acerta Pharma Acerta Pharma is a biopharmaceutical company.	Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Founding Date	Founding Date 2015	Founding Date 1993	Founding Date 2013	Founding Date 2009
Type	Type Public	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Woburn, US HQ Milton, GB Woburn, US	Locations Shenyang, CN HQ	Locations South San Francisco, US HQ Oss, NL Oss, NL	Locations Boulder, US HQ Paris, FR München, DE Dublin, IE Milano, IT Madrid, ES Zürich, CH see more
Employees	Employees 10422% increase	Employees 5,2325% decrease	Employees 197	Employees 4843% increase
Valuation ($)	Valuation ($) 1.1 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 10.6 m
Employee Rating	Employee Rating 3.3	Employee Rating 3	Employee Rating 3.5	Employee Rating 3.8
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥6.4b (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $148.8m (FY, 2021)
Net income	Net income ($118m) (FY, 2022)	Net income ¥1.6b (FY, 2021)	Net income N/A	Net income ($264.5m) (FY, 2021)
Funding
Total funding raised	Total funding raised $ 30m	Total funding raised $ 15.2m	Total funding raised $ 60m	Total funding raised $ 357m